Frost F, et al. - Researchers determined the impact of continuous glucose monitoring (CGM) guided insulin initiation on the outcomes (including weight and pulmonary function changes over the next 12 months) in adults without a prior diagnosis of cystic fibrosis related diabetes (CFRD) presented at their centre. They analyzed CGM profiles for 59 patients and started insulin therapy in 37 patients who had evidence of hyperglycaemia on CGM. Findings demonstrated that improvements in lung function (improved forced expiratory volume in 1 s) and weight with subsequent reduced pulmonary function decline was observed in association with insulin treatment targeted towards glycaemic excursions seen on CGM.